A few more thoughts on Precision Medicine
Had this piece run in the April issue of Scientific American, and got a bit of flack from the precision medicine enthusiasts out there. They were particularly incensed that I wrote dismissively of Gleevec, the cancer drug that made headlines back in 2001, when it was found to work against CML (chronic myelogenous leukemia). Gleevec … Continue reading A few more thoughts on Precision Medicine
Science & Story 